Compare Qurate Retail Inc Series A (QVCAQ) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Qurate Retail Inc Series A vs Recursion Pharmaceuticals Inc — how do they compare? Qurate Retail Inc Series A trades at $0.04 (market cap $653.75K), while Recursion Pharmaceuticals Inc trades at $3 (market cap $1.63B). The key difference: Recursion Pharmaceuticals Inc is far larger — about 2493.3× Qurate Retail Inc Series A's market cap. Which is the better fit depends on your goals.
| QVCAQ | RXRX | |
|---|---|---|
Market Cap | $653.75K | $1.63B |
Sector | Consumer Cyclical | Health |
52-Week High | $15.03 | $6.79 |
52-Week Low | $0.05 | $2.84 |
Enterprise Value | $4.73B | $1.05B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Qurate Retail Inc Series A
Qurate Retail Inc, through its subsidiaries, is engaged in the video and online commerce industries. Its segments include QxH, which includes QVC U.S. and HSN market and sell a wide variety of consumer products in the United States, primarily using their televised shopping programs and via the Internet through their websites and mobile applications
Read more on QVCAQ →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
